Showing posts with label Ingenious Investor. Show all posts
Showing posts with label Ingenious Investor. Show all posts

Monday, March 25, 2013

Smart Investor - Weekly Analysis 25 March 2013


Traders will have field day with wild swings expected on both sides.  Only brave hearts and those who can afford to lose money quickly should venture.

For investors this is a time to take a break from the market and keenly await the Advance Tax numbers for pointers.  Stay away from market and track the market on sidelines.

Avoid PSU basket as more carnage is expected in Coal India, Engineers India, Hindustan Copper.

Smart Investor
Equity Research Division

Ravina Consulting
No.24 Pattamal Plaza
3rd Cross, Kammanahallli
BANGALORE 560084

For Stock Advise + Ideas
sowmya@ravinaconsulting.com
Talk / SMS 08105737966

Read - www.ingeniousinvestor.blogspot.com
Follow us - www.twitter.com/smartinvestor
http://www.google.com/profiles/intellinvestor




Saturday, December 8, 2012

PC Jewellers - IPO - Apply


Compared to the public issues of Tribhovandas Bhimji Zaveri (TBZ) and Tara Jewels, PC Jeweller’s initial public offering (IPO) is priced lower, at a PE of 9.7-10.5 times FY12 earnings (considering post-issue capital). But that is for a reason.


Though the promoters have more than two decades of experience in the jewellery business, the company is relatively new (compared to its nearest competitors, particularly TBZ) in the jewellery retailing business. Second, its operations are concentrated in the northern region, with Delhi NCR forming 57 per cent of domestic revenue in the first half of FY13. On the flip side, it has reported strong growth in the past, coupled with healthy margins. Growth rates should remain healthy and geographical concentration risk will ease, thanks to expansion. In this backdrop, investors can subscribe to the offer.


The company is engaged in manufacture, retail and export of jewellery, with five manufacturing facilities spread over 83,000 sq ft. Exports (on a wholesale basis to international distributors) formed 33 per cent of revenues in the year’s first half, but its share is expected to go down with a focus on domestic business.

By FY14-end, the company aims to have 50 owned-stores across India, from 30 stores in 23 cities and eight states currently, with addition of 20 stores (half in the western and southern; rest in north and east), which is to be funded through the IPO proceeds. Retail area would also jump 81 per cent from the current 164,000 sq ft. While the expansion should mitigate the geographical concentration risk, establishing a strong brand name (as in northern India) in the new regions might not be easy.

The company’s ‘Jewels for Less’ scheme (50,000 members) started just two years earlier, has seen good response and its policy of ‘full refund’ for jewellery returned within seven days of purchase are positives and should help on this front.

The company has reported rapid and profitable growth in a short span of time, which instils confidence. Says CRISIL in its IPO grading note, “The pace of expansion has been faster compared to other players with addition of 25,000 sq ft every year. The stores have been profitable from the first year of operations."

Apart from expansion, sales growth (CAGR of 70 per cent in FY09-12, highest among its competitors) is also aided due to a focus on wedding jewellery (80 per cent domestic revenues), the largest segment and relatively less affected by slowdown since it is an essential (planned) purchase.

The company’s strategy is to open large formats (average size per store of 5,500 sq ft). Of the 30 stores, 27 have an area of over 3,000 square feet each, which includes 11 showrooms of more than 5,000 sq ft each (four above 10,000 sq ft).

Says Balram Garg, managing director of the company, “The large format reinforces our positioning as trusted jewellery retailer, enabling us to attract a diverse customer base, offers a wide range of jewellery, ensures effective inventory management and provides benefits of scale."

Put together, these moves along with the increasing contribution of diamond jewellery (32 per cent of revenues in the first half from 18 per cent four years ago) have led to higher operating profit margin (OPM) than its peers. And there is further scope for margin improvement. Says Garg, “We are more focused on bottomline growth as it will help expand our network faster." Declining share of exports in total mix will also help. Buying gold on lease basis (against purchase) since inception has ensured less pressure on the balance sheet. All these have helped net profit grow at a faster pace.


Smart Investor 
Equity Research Division

Ravina Consulting
No.24 Pattamal Plaza
3rd Cross, Kammanahallli
BANGALORE 560084

For Stock Advise + Ideas
sowmya@ravinaconsulting.com
Talk / SMS 08105737966

Read - www.ingeniousinvestor.blogspot.com
Follow us - www.twitter.com/smartinvestor
http://www.google.com/profiles/intellinvestor

Monday, November 5, 2012

Buy - Sun Pharma Advanced


We recommend a buy in the stock of Sun Pharma Advanced Research Company from a long-term horizon. It is seen from the charts of the stock that it has a significant long-term support in the base band between Rs 75 and 87. In the past, the stock has consistently reversed upwards whenever it had tested the aforesaid support band. 
Similarly, the stock took support from this support level in mid-June this year and bounced up. Since then, the stock has been on a modest medium-term uptrend. The stock surged 10 per cent with good volume, emphatically breaching its moving average compressions (21-, 50- and 200-day moving averages) at Rs 79 and its immediate resistance around Rs 95 on Tuesday.
We observe that there is an increase in daily volume in the past two trading sessions. The daily relative strength index is featuring in the bullish zone and weekly RSI is on the brink of entering this zone from the neutral region. The daily moving average convergence divergence indicator has signalled buy and is about to enter positive terrain.
We are bullish on the stock from a short-term perspective. We expect its rally to prolong and reach our price target of Rs 110 in the months ahead. Traders with near-term perspective can buy the stock with stop-loss at Rs 90 levels.
Bought to you by
Smart Investor
Equity Research Division 
Ravina Consulting
Pattamal Plaza
3rd Cross Kamanahalli
BANGALORE 560084
For Free Stock Advise + Ideas
Talk / SMS 08105737966 
Follow us -

Sell Bharath Forge




We recommend a sell in the stock of Bharat Forge from a short-term perspective. It is apparent from the charts of the stock that following a medium-term downtrend from its May 2012 peak of Rs 347, the stock took support at around Rs 275 last month. This support level also coincides with the 61.8 per cent fibonacci retracement level of the stock's prior up move. After testing the support at Rs 275, the stock bounced up. 

The stock's reversal is backed by a positive divergence in daily relative strength index and daily price rate of change indicator. Moreover, the stock breached its immediate resistance as well as 21-day moving average at around Rs 290 by gaining almost 3 per cent on Saturday. Both daily and weekly relative strength indices are moving higher in the neutral region towards the bullish zone. The daily price rate of change indicator has entered the negative territory implying buying interest. The daily moving average convergence divergence indicator has signalled a sell. 

We are bearish on the stock from a short-term perspective. We expect the stock’s down move to continue and reach our price target of Rs 250 or Rs 225 in the November month. Traders can consider buying the stock around 250 while maintaining stop-loss at Rs 230 levels.

Bought to you by
Smart Investor
Equity Research Division 
Ravina Consulting
Pattamal Plaza
3rd Cross Kamanahalli
BANGALORE 560084
For Free Stock Advise + Ideas
sowmya@ravinaconsulting.comTalk / SMS 08105737966 
Follow us -

Monday, October 1, 2012

October 2012 - Bull run likely to continue


Ever since the government shunned its lethargy to announce some bold policy measures a fortnight ago, the equity markets have made significant headways with the Sensex rising nearly 1,000 points. 

However, market players believe that policy movements stalled over the past few years have given a new dimension to overall sentiments, and hope that the mood will remain upbeat in the near-to-medium term as fundamentals improve. The decision to allow higher foreign direct investment in aviation and retail sectors, besides increasing diesel prices and partially lifting subsidy on LPG, has triggered optimism among investors, especially FIIs. 

G Chokkalingam, ED & CIO, Centrum Wealth Management, said, “I believe the rally will sustain because there is a fundamental conviction which is driving markets. The opening up of foreign investments has set the tone. In valuation terms, Sensex PE (price-earnings) is trading at just 18 times compared with 28 times the index had commanded at the peak of 2007. The government is likely to keep up the pace of reforms, with banking amendments and insurance bill coming up next. India is a unique market and FDI in aviation and retail would provide a big boost to sentiments. We expect the rupee to appreciate up to 52 against the dollar by December and to 45 in the next one year. This will boost foreign fund inflows in a big way.” 

“The Trinamool Congress leaving the government has been a blessing in disguise for the markets. Now the government can push ahead with its reform initiatives. With either the BSP or the SP providing support to the UPA government, it should be possible for the centre to proceed with reforms,” Chok­kalingam said. 

Foreign investors have pumped in over Rs 18,000 crore into local equities in September, helping Sensex to rise nearly 8 per cent. So far, the Sensex has surged 21 per cent this calendar, boosted by foreign fund inflows of Rs 81,700 crore, or nearly $16 billion. Going by the statistics, Sensex has given positive returns in October in five of the past 10 years (see chart). Last year, the bellwether index rose nearly eight per cent in October, holding out hope that the trend would continue this October as well.

Kishor Ostwal, CMD of CNI Research, said, “The markets will rally despite the government’s not-so-impressive performance on the reforms front. They have not addressed the fiscal slippage issue. The market was oversold and hence we saw a big rally. We expect small profit-booking before Nifty rebounds thereafter. We expect Nifty to reach 5,800 in October.” 

Following the announcement of the reform measures, several foreign brokerages upgraded the Sensex target for the year. Buoyed by the back-to-back announcements on fuel price hike and relaxing FDI norms for retail, aviation, power exchanges and broadcasting services, Citibank increased its Sensex target to 19,900 from 18,400 earlier, while Deutsche Bank forecast that the index would reach the 20,000 level by calendar end instead of its targeted 18,000 level at the start of the year. 

Morgan Stanley has raised its Sensex target for December 2013 to 23,069. BNP Paribas has indicated the revival in domestic animal spirits coupled with likely increase in global liquidity on the back of quantitative easing by the US Fed Reserve has priced out the risks faced by India over the next six-twelve months, thereby justifying the jump in equities and currency.  Citi report said the recent reforms announcement would perk up market sentiments while a mix of fairly real policy changes and global liquidity (QE3) should push Sensex higher by two to three per cent in the immediate term.

“We expect the index to continue with its tendency of 50 per cent retracement of each up-leg. The support region of 18,250-18,000 is likely to act as a launch pad for further upward rally. The next up-leg is expected to take the index towards 19,500-19,800 being the 78.6 per cent retracement of the entire decline from November 2010 high of 21,108 to December 2011 low of 15,135,” ICICIdirect said in its report. 

Market men also reckon the recent steps taken by the government to restructure the financials of state electricity boards should augur well for the power sector in the medium-to-long term.  Further, with State Bank of India taking the lead and slashing interest rates, there was hope that the high interest rate regime could be bottoming out. “One can expect other banks to follow soon in paring down lending rates,” Chokkalingam said. Lower interest rates would kickstart the investment climate and provide a leg-up to earnings over the next four-five quarters. 

The equities market will also take cues from September quarter earnings set to be announced from this month. There will not be any major disappointments in earnings and one may expect 10-11 per cent sequential growth in the July-September quarterly earnings, Chokkalingam said. Crisil Research in its report has indicated a 20-40 basis points expansion in Ebitda margins year-on-year in the forthcoming July-September earnings. 

Its study has highlighted that Ebitda margins are bottoming out after falling for the past nine quarters, as softening commodity prices and higher realisations for export-centric companies amid falling rupee would aid margins. Companies representing cement, power, steel, tyres and textiles were expected to benefit from a sharp decline in commodities such as coal, rubber and cotton, while the rupee depreciation would continue to boost margins of IT services and pharmaceuticals sectors, the Crisil report said


Bought to you by
Smart Investor
Equity Research Division 
Ravina Consulting
Pattamal Plaza
3rd Cross Kamanahall
iBANGALORE 560084

For Free Stock Advise + Ideas
sowmya@ravinaconsulting.comTalk / SMS 08105737966 
Follow us -

Wednesday, August 15, 2012

Pratibha Industries- BUY


Dear Smart Investors,



Pratibha Industries declared strong set of numbers for the quarter ended June '12, which were in line with SPA Securities' estimates. While PIL reported a topline growth of 55.4% to Rs5598 mn driven by strong execution of order book, sharp surge in interest and depreciation expenses restricted the net profit growth by 22.2% to Rs228 mn. Operating margins improved by 107 bps aided by its high margin water projects. Order inflow remained strong as PIL booked orders worth Rs15 bn leading to total order book Rs66 bn (3.5x TTM revenues), thereby ensuring healthy revenue visibility for the next couple of years. SPA retains their BUY recommendation on the stock with a target of Rs68.

Superior execution driving revenues
PIL reported strong revenue growth of 55.4% to Rs5598 mn in Q1FY13 on the back of 66.3% growth in the construction segment. The growth was led by strong execution of ongoing projects and ramp up of revenue recognition from Delhi Metro and Delhi Jal Board project. The manufacturing division continued to disappoint with 57.3% decline in revenues. 50% of the revenue was from water segment, 35% from Urban Infrastructure segment and balance from building segment.

Healthy margins
EBIDTA in Q1FY13 grew at faster pace by 67.7% to Rs821 mn largely on the back of 107 bps improvement in operating margins to 14.3% owing to execution of high margin water projects. Commencement of revenue recognition from some of the large projects bagged in the last financial year also aided in margin improvement.

Higher interest & depreciation expense dents profitability
Net profit grew at slower pace of 22.2% to Rs228 mn and PAT margins plunged by 111 bps to 4.1% in Q1FY13. This was led by sharp surge of 2.2x in interest expense to Rs432 mn due to increased borrowings & 50.1% increase in depreciation expenses to Rs65 mn.

Healthy order book provides sound revenue visibility
PIL has a robust and well diversified order backlog of ~Rs66 bn (3.5x its TTM revenues) as on June '12 with an average execution period of 30 months, which offers strong revenue visibility for PIL over the next couple of years. 40% of orders are from water space, 25% from urban infra and 35% are from building. Order inflow remained strong at Rs15 bn in the last quarter (from tunnelling and building segment) PIL has placed bid for several projects and is L1 in projects worth Rs22 bn.

Going forward SPA expects PIL to maintain an order inflow run rate of ~Rs40 bn in each of the next two years, which would lead to 23% CAGR in order backlog over FY12-14E.

Merger of Pratibha Pipes & Structures - On track
The merger process is on track and PIL had convened shareholders meeting on 5th June to approve the scheme. Now the scheme is under active consideration of Bombay High Court and the whole process is expected to take another 2-3 months for completion.

Outlook & Valuations
SPA remains positive on the infrastructure sector and PIL with proven track record & efficient project delivery mechanisms is expected to be one of the prime beneficiaries of emerging opportunities in the sector. With the expected economic recovery, SPA expects sharp rerating of the stock with market pricing in its focussed approach, strong order backlog and sustainable high margins.

At the CMP of Rs48, the stock trades at a P/E and EV/EBIDTA of 3.9x and 4.5x its FY14E earnings respectively



52 week Price Movements NSE

http://www.google.com/finance?chdnp=1&chdd=1&chds=1&chdv=1&chvs=maximized&chdeh=0&chfdeh=0&chdet=1345041939004&chddm=1128&chls=IntervalBasedLine&q=NSE:PRATIBHA&ntsp=0

Our Recommendation :
Buy on declines around Rs.45 for a target of Rs.68 holding period of 3-4 months.


Bought to you by

Smart Investor
Equity Research Division

Ravina Consulting
Pattamal Plaza
3rd Cross Kamanahalli
BANGALORE 560084

For Free Stock Advise + Ideas
sowmya@ravinaconsulting.com
Talk / SMS 08105737966

Follow us - www.twitter.com/smartinvestor
Read - www.ingeniousinvestor.blogspot.com
Like us - www.facebook.com/IngeniousInvestor


Thursday, August 9, 2012

Sugar Stocks - Buy on declines

Investors,

The sugar stocks have run up quite smartly during the last 1 month and they are now looking overbought.

Buy on declines of around 10% in the upcoming weeks.  We give below the buy and sell ranges for the top 5 picks in the sector

Balrampur Chini Buy - Buy around Rs.55 levels target price of Rs.75
Bajaj Hindustan Buy - Buy around Rs.30 levels target price of Rs.50
Triveni Engineering - Buy around Rs.18 levels target price of Rs.35
Shree Renuka Sugars - Buy around Rs.30 levelstarget price of Rs.50
KCP Sugars - Buy around 15 levels target price of Rs.25

Holding Period - 6 months

Related post -

 Ambareesh Baliga, COO, Way2Wealth 
 told CNBC-TV18, “Sugar space, I am cautious at these levels because unlike last time when we had the sugar prices moving up, I think the inventory levels this time are much lower and last time I suppose most of the profits was from the inventory which was there and not really from operations.”


He further added, “So this time also I expect that the margins still would be under pressure going ahead with cane prices moving up because of monsoons which we have. So I think the upside is quite limited. Possibly a stock like Shree Renuka  could move to levels of about Rs 36-37 but going beyond that would everybody quiet difficult.”

Bought to you by

Smart Investor
Equity Research Division

Ravina Consulting
Pattamal Plaza
3rd Cross Kamanahalli
BANGALORE 560084

For Free Stock Advise + Ideas
sowmya@ravinaconsulting.com
Talk / SMS 08105737966

Follow us - www.twitter.com/smartinvestor
Read - www.ingeniousinvestor.blogspot.com
Like us - www.facebook.com/IngeniousInvestor



Monday, July 16, 2012

Bata India - Buy on declines



"Bata India Ltd. (BIL) focused on premium products and sacrificed volume, which grew by a mere 1.1% in CY11. It has started focusing again on volume and as a result, volume grew 14% in 1QCY12. As per the management, volume growth is expected to remain in double-digits in CY12. Strong volume growth along with higher realisation (due to better product mix) should result in revenue growing 20.0-25.0% as against our estimate of 19.7% in CY12E. Revenue has already grown by a robust 30.6% in 1QCY12. The management is confident of doubling its revenue in the next four-five years."

"BIL opened ~67 new outlets (including Hush Puppies stores) in 1QCY12. It set up ~25 more stores in 2QCY12 and new store addition has already touched ~92 in 1HCY12, which is expected to be ~150-170 by the end of CY12. Of the total 146 outlets opened in CY11, around 53% were opened in 2HCY11, which resulted in high inventory and lower revenue from these outlets in CY11. Currently, BIL is front-loading the setting up of new outlets and out of the total target of ~150-170 outlets planned in CY12, it has already opened ~92 outlets in 1HCY12. BIL has started bar-coding its products and currently 60-70% of its products are bar-coded. As a result, BIL would be able to report healthy revenue growth and also control its inventory in CY12. BIL plans to incur a capex of Rs1,000mn - ~Rs700mn in retail and ~Rs300mn in upgrading its manufacturing facility - in CY12E."

"Footin, owned by BSO (Bata Shoe Organization), is very popular in Thailand, Bangladesh etc, catering to college-going youth in the range of 15-25 years. BIL launched Footin in India in 1QCY12, with its USP being contemporary designs at an affordable price of Rs500-700/pair. In order to de-link Bata’s brand image, BIL is setting up exclusive Footin outlets of 1,000-1,500 sq ft. It has already opened nine Footin outlets till now in Delhi and Mumbai, where the response has been excellent. Currently, the exercise is more of a trial and if the response stays buoyant, BIL plans to aggressively open Footin outlets in the next two-three years. BIL is also very bullish on kids and women segments and is looking at launching new brands, either BSO-owned or strong in-licensed brands, in India."

Valuation

"We expect BIL, which trades at CY13E P/E of 22.3x and EV/EBITDA of 13.5x, to witness a further re-rating. On the back of strong revenue/net profit CAGR of 18.8%/31.2%, respectively, likely over CY11-13E, BIL would continue to trade at premium multiples. The stock is attractively priced, with a PEG ratio of 0.87x CY12E," says Nirmal Bang research report.

Recommendation  

Bata was quoting around 530 levels on Jan 2, 2012 and has so far given investors a decent 60% appreciation.  There is more steam left in the stock as we believe it is likely to cross Rs.1000/- levels.

Smart Investor
Equity Research Division

Ravina Consulting
No.24 Pattamal Plaza
3rd Cross Kamanahalli
BANGALORE 560084

For Free Stock Advise + Ideas
sowmya@ravinaconsulting.com
Talk / SMS 08105737966

Monday, March 5, 2012

Sesa Sterlite Merger - Buy Sterlite

Vedanta Resources PLC on 25 February 2012 announced the merger of all its key investments in India into a single company called 'Sesa Sterlite'. The new holding company will own controlling stakes in all of Vedanta's companies in India and would be a metals, mining and natural resources giant. The merged entity would be India’s natural resources company and is expected to be seventh largest global diversified natural resources major on EBITDA basis. By this exercise, the group structure has also been simplified and cross holdings have been eliminated, which is expected to benefit the group through superior capital structure, increased flexibility to allocate capital, broader access to capital markets and enhanced visibility of earnings and cash-flow. In addition to this, increased diversification is expected to reduce volatility of earnings through commodity cycles, lowering the cost of capital and enhancing value. As per the management, the transaction is expected to be completed in CY12 and the synergies are expected to generate cost savings of Rs10bn per annum.

Restructuring done to lighten up Vedanta Plc balance sheet
Indiainfoline believes that restructuring has been done largely to lighten the parent company’s balance sheet, bring in synergies between VAL and Sterlite Energy (SEL), use the accumulated losses at VAL and reduce the financing costs for the company. Vendanta Resources Plc, the parent company had taken loan to the tune of US$2.8bn to acquire stake in Cairn India, which was to be repaid over the next two years. In addition to this, the parent company had to infuse equity in its loss making subsidiary VAL to fund its capex. Sterlite, 29.5% stake holder, had invested more capital in VAL than its equity contribution over the last two years.

Sterlite to witness buying
The merger ratio would boost Sterlite’s stock in the near term as it is done at a premium to Friday’s closing of Rs119. On the other hand, we expect it to be negative for Sesa Goa as the debt of VAL would be shared on its books. Indiainfoline believes the deal is largely done in a fair way except the valuation of VAL. The merged company would be a must own entity as it would provide a large diversified portfolio under one roof. Indiainfoline values the merged entity ‘Sesa Sterlite’ on sum-of-the-parts method. They have used EV/EBIDTA method to value the metal assets, price/book for the power and a holding company discount to Cairn India. They derive a target price of Rs217 per share for Sesa Sterlite (and Sesa Goa) which on an implied basis (swap ratio of 0.6x as per deal) indicates a target price of Rs130 for Sterlite. Indiainfoline maintains their ‘Market Performer’ rating on Sesa Goa and our ‘BUY’ rating on Sterlite.

Restructuring exercise
The restructuring exercise includes merger of four companies viz Sterlite Industries, Sesa Goa, Vedanta Alumina and MALCO and transfer of Vedanta’s stake in Cairn India to the merged entity with an associated debt. The steps for the proposed transaction are:

1) Sterlite will merge into Sesa Goa to create Sesa Sterlite, through the issue of Sesa Goa shares to shareholders of Sterlite. Sterlite shareholders as of the record date are expected to receive 3 Sesa Goa shares for every 5 existing Sterlite shares. Sesa Goa also intends to establish an ADS facility comparable to Sterlite’s current ADS. This would allow holders of Sterlite’s ADS as of the record date to receive Sesa Goa ADS with appropriate adjustments to reflect the foregoing exchange ratio. Each Sterlite ADS currently represents four equity shares of Sterlite.

2) Consolidation of VAL, via the merger of Ekaterina Limited (a Mauritius holding company for Vedanta’s 70.5% shareholding in VAL) into Sesa Sterlite and the issue of 72.3mn Sesa Goa shares to Vedanta after obtaining all necessary approvals. Based on Sesa Goa’s closing price on 24 Feb 2012 of Rs227/share, the equity value of VAL equates to Rs23.32bn (US$473mn).

3) MALCO to merge into Sesa Sterlite, through the issue of 78.7mn Sesa Goa shares to shareholders of MALCO as of the record date. Based on Sesa Goa’s closing price on 24 Feb 2012 of Rs227/share the value of MALCO equates to Rs17.9bn (US$363mn) including the value of MALCO’s existing 3.6% shareholding in Sterlite. As part of the merger MALCO’s existing shareholding in Sterlite will be cancelled by Sesa Sterlite.

4) Post the merger of Sesa Goa and Sterlite, Sterlite Energy Limited and VAL’s Aluminium business will be merged into the consolidated Sesa Sterlite. As wholly-owned subsidiaries no shares will be issued in consideration of the mergers. 

5) Vedanta will transfer its 38.8% direct shareholding in Cairn India to a wholly-owned subsidiary of Sesa Goa at a nominal consideration of US$1, together with the associated acquisition debt of $5.9bn (coupon of 5.2%). The debt will continue to be guaranteed by Vedanta. This transfer is not inter-conditional on the merger of Sesa, Sterlite, MALCO and VAL.

Positives of the deal:
- Consolidated balance sheet to be stronger and would reduce the cost of funds for the companies.
- Increased diversification is expected to reduce volatility of earnings through commodity cycles, lowering the cost of capital and would enhance value.
- Accumulated loss of Rs15bn at VAL would reduce the tax out flow for the group.
- Overhang of merger of VAL with Sterlite is over.
- With the merger of SEL and VAL aluminium, the capex for VAL’s power plants would reduce.
- Shareholders of Cairn India and HZL would receive higher dividend over the next two years as the merged entity has high debt repayment.
- Positive for Sterlite shareholders in the near term as the deal is done at a premium to Friday’s closing price of Rs124.


Our Recommendation :


If you are presently holding Sesa Goa shares look to sell around 225 levels.  Long term investors should buy Sterlite Industries on all dips and hold for 2-3 years for a 100% return



Bought to you by


Smart Investor
Equity Research Division


Ravina Consulting
Pattamal Plaza
3rd Cross Kamanahalli
BANGALORE 560084


For Free Stock Advise + Ideas
sowmya@ravinaconsulting.com
Talk / SMS 08105737966


Follow us - www.twitter.com/smartinvestor
Read - www.ingeniousinvestor.blogspot.com
Like us - www.facebook.com/IngeniousInvestor






Sunday, February 12, 2012

Banking Sector - Book Profits


Overseas investors seem to be on a selling spree when it comes to the Indian banking stocks, as they have pared their holdings in at least 28 public and private sector banks of the country in the past few months.
Various foreign investors have together sold banking stocks worth an estimated Rs 10,000 crore (over USD 2 billion) in about four-and-a-half months since October 2011.

While foreign investors have sold shares of at least 28 Indian banks, they have purchased fresh shares of only nine banking stocks during this period. The value of fresh banking shares purchased during this period is also much less at just about Rs 600 crore, as per an analysis of shareholding pattern and open-market transaction data available with stock exchanges.

The banks where foreign investors have pared their holdings include private players like ICICI Bank, Axis Bank, Kotak Mahindra Bank, Yes Bank and DCB, as also public sector giants like SBI and Punjab National Bank. Those having seen an increase in the holding of overseas investors include HDFC Bank, South Indian Bank and IDBI Bank.

In one of the biggest share-sale transaction in the banking sector during this period, a unit of Singapore government's investment arm Temasek Holdings sold shares worth about Rs 1,500 crore in ICICI Bank on
Market analysts said the shares could have been sold to book profit after a sharp rally of about one-third in ICICI Bank shares since the beginning of 2012.

Indian banking and financial sector stocks have witnessed many share transactions in the recent past, given a sharp surge in their value since the beginning of 2012.   While US-based Carlyle group sold shares worth about Rs 1,350 crore in HDFC on February 1, Warburg Pincus sold shares accounting for about 2.4 per cent stake in Kotak Mahindra Bank for about Rs 800 crore on the same day.

Besides, the shareholding pattern data for the October- December 2011 quarter shows that FIIs (Foreign Institutional Investors) lowered their holding in 26 banks.  These included ICICI Bank, SBI, Axis Bank, DCB, Yes Bank, Allahabad Bank, Indian Bank, Corporation Bank, Bank of Baroda, Canara Bank, Dhanlaxmi Bank, Karnataka Bank, among others.

In fact, the banking sector witnessed the highest level of share sale by FIIs during that quarter. Also, a few like PNB, SBI, Syndicate Bank, Allahabad Bank and Central Bank have seen their FII holdings declining for four consecutive quarters now.  On the other hand, the FII holding increased during the last quarter of calendar year 2011 in banks like South Indian Bank, Bank of India, City Union Bank, IDBI Bank, Indian Overseas Bank, Federal Bank, Andhra Bank, HDFC Bank and ING Vysya Bank.

Our Recommendation :
With  most of the banking shares clocking decent gains of 30-50% gains, it is time to book profits and stay away from the sector as it faces stiff resistance at higher levels.  Long term investors can however utilize steep falls to add banking scrips to their portfolio.



Bought to you by

Ingenious Investor
Equity Research Division

Ravina Consulting
Pattamal Plaza
3rd Cross Kamanahalli
BANGALORE 560084

For Free Stock Advise + Ideas
sowmya@ravinaconsulting.com
Talk / SMS 08105737966

Follow us - www.twitter.com/smartinvestor
Read - www.ingeniousinvestor.blogspot.com
Like us - www.twitter.com/IngeniousInvestor

BSE / NSE Weekly Review Feb 11, 2012




Key benchmark indices rose in the week ended 11th February 2012, as inflows from foreign
institutional investors (FIIs) remained robust. This was the 6th consecutive weekly gain. Trading
remained upbeat throughout the week. However, some profit booking emerged on Friday (10
February 2012) after disappointing industrial production data for the month of December 2011
dampened investor sentiment.

Industrial production rose a slower-than-expected 1.8% in December 2011, government data
showed on Friday, 10 February 2011. The growth in December 2011 was sharply lower than
5.9% growth in November 2011. Manufacturing output, which constitutes about 76% of industrial
production, rose 1.8% from a year earlier, the federal statistics office said.

India's January exports rose 10.1% to $25.4 billion while imports rose 20.3% to $40.1 billion,
leaving a trade deficit of $14.7 billion, Trade Secretary Rahul Khullar said on Thursday. India's
exports reached $242.8 billion between April and January, Khullar said, citing provisional data.
The BSE Sensex rose 0.8% to 17,749 in the week ended Friday, 10th February 2012 while the
S&P CNX Nifty rose 1.1% to 5,382. The rise in the broader indices was amplified. The BSE MidCap index rose 3.3% to 6,247 while the BSE Small-Cap index rose 3.1% to 6,891. The sectoral
indices sentiments were extremely positive with the Healthcare index being the only loser. BSE
Realty, BSE CD and BSE Metal were the largest gainers.

Realty: 
The BSE Realty index rose 5.8% to close at 1,887 levels. Among the heavyweights, DLF rose
marginally (0.2%) while Unitech and HDIL jumped significantly (12.9% and 18.0% respectively)
in the week. Shares in real estate companies were up on expectations of a pick-up in deal flows
and a fall in interest rates, which would benefit both builders and real estate buyers. Unitech
rose on account of pressure from the Norwegian government to survive Uninor, a venture by
Telenor and Unitech Ltd. Telenor, in which the Norwegian government has a ~54% stake, owns
nearly two-thirds of Uninor with infrastructure provider Unitech holding  the rest. Norway’s IT
minister, Rigmor Aasrud, met her Indian counterpart, Kapil Sibal, to discuss the Supreme Court’s
cancellation of licenses of telecom operator Uninor.


Consumer Durables (CD): 
The BSE CD index rose 5.8% to close at 6,169 levels. Among the heavyweights, Titan, Rajesh Exports and Gitanjali rose 5.3%, 2.4% and 5.5% respectively while Videocon fell 1.1%. TTK Prestige rose a whamming 38.9% in the week, establishing its spot among the large companies by market cap within the CD space. The company  clarified that it did not intend to exit the modular kitchen business but plans to expand it slowly after gaining experience. The company also has a plant coming up in Gujarat, which will add to the topline significantly.



Metals:  
The BSE Metals index rose 4.1% to close at 12,364 levels. All the industry majors were gainers. Tata Steel and Coal India rose 1.7% each while Jindal Steel, Hindalco and Sterlite rose 8.5%, 0.2% and 5.1% respectively. Tata Steel issued an encouraging future outlook after reporting 3rd quarter consolidated net loss of Rs 603 cr as  against net profit of Rs 1003 cr in Q3FY11. Turnover rose 13.79% to Rs 33103 cr in Q3FY12 over Q3FY11. With regard to future outlook, Tata Steel said softening raw material prices is expected to ease product-costing pressures from Q4FY12 onwards. Tata Steel expects steel demand in India to improve with RBI indicating progrowth monetary policy. Steel prices remain firm and with traditionally strong volumes in the fourth quarter and the company's profitability is  expected to improve.

The outlook for steel demand in Europe remains stable. Strengthening  steel prices in Europe and restocking will result in better margins of Tata Steel’s European operations in the coming quarters. Tata Steel’s South East Asian operations are expected to perform better with activities in Thailand coming back to normal. Reconstruction activities  will boost long products demand. Jindal Steel and Power plans to spend $300 million in developing new and existing mines in Africa. The move is part of the company's strategy to source coal assets abroad to meet raw material demand of its steel and power plants at home.

Bankex: 
The BSE Bankex index rose 3.0% in the week to close at 11,987 levels. All the large players, namely ICICI Bank, HDFC Bank, SBI and Axis Bank, were gainers, rising 1.5%, 1.9%, 3.3% and 1.6% respectively. SBI recently said that the Government of India has agreed to inject approximately Rs 7900 crore into bank by way of preferential allotment of equity shares to help SBI achieve minimum 8% Tier I CAR by 31  March 2012. The government currently owns 59.40% of SBI. HDFC Bank hit a record high on Friday. A unit of Singapore state investment company Temasek Holdings Pte sold 1.59 crore shares of ICICI Bank through bulk deals on NSE for Rs 1472 crore during the week. Allamanda Investments Pte sold the shares in India's
largest private-sector lender by assets at an average Rs 924.05 per share in the week. Goldman Sachs Investments Mauritius mopped up 64.65 lakh shares in the bulk deal at a price of Rs 924 per share.

PSU: 
The BSE PSU index rose 2.5% in the week to 7,673 levels. ONGC, Coal India, NTPC and SBI rose 0.3%, 1.7%, 2.0% and 3.3%. As mentioned previously, the Government of India has agreed to inject money into SBI. NTPC paid an interim dividend of Rs 2,885.92 cr for the current fiscal. Net profit of the company rose 10% to Rs 2,130.39 crore for the quarter ended December 31,
2011 due to increase in coal prices.

Healthcare (HC): 
The BSE Healthcare (HC) index was the only loser in the week, falling 1.0% to close at 6,347. Among the giants, Sun Pharma, Dr. Reddy’s and Lupin were losers, falling 2.7%, 3.0% and 4.1% respectively while Cipla rose 1.2%. Lupin Limited is planning to invest $20 million in setting up a new manufacturing facility in Pune. Lupin will also launch a cancer drug, which is yet to go through the third clinical trial. It is expected to hit the market during the next financial year.






Bought to you by

Ingenious Investor
Equity Research Division

Ravina Consulting
Pattamal Plaza
3rd Cross Kamanahalli
BANGALORE 560084

For Free Stock Advise + Ideas
sowmya@ravinaconsulting.com
Talk / SMS 08105737966

Read - www.ingeniousinvestor.blogspot.com
Follow us - www.twitter.com/smartinvestor
Like us www.facebook.com/ingeniousinvestor

Tuesday, February 7, 2012

Bank Nifty / Bankex Review - Buy on declines


Top 5 Private Sector Banks - Buy on declines

We have done detailed analysis of the Q3 results of private sector bank and following is the summary of our Report.

One week returns

Bank Nifty 3.25%
HDFC  4.76
ICICI 2.96
Kotak 6.03
Axis 2.16
Yes 5.28

One month returns

Bank Nifty - 19.85%
HDFC 14%
ICICI 22.44%
Kotak 16.53%
Axis 26.50%
Yes 38.39%

3 months returns

Bank Nifty - 3.02%
HDFC  4.83%
ICICI 3.64%
Kotak 3.14%
Axis -2.50%
Yes 8.25%

Six Months returns

Bank Nifty - 2.12%
HDFC  6.95%
ICICI -6.01%
Kotak 18.85%
Axis -11.88%
Yes 13.08%

Our Recommendation - With Buy and Sell ranges given below

Bank Nifty

HDFC  475 - 540
ICICI 850 - 935
Kotak 450 - 550
Axis 950 - 1260
Yes 315 - 365

Look for a correction of about 8-10% and buy the above stocks on dips.  The banking sector is likely to do well in the coming months and will support both the Nifty and Sensex to stay higher.

Bought to you by

Ingenious Investor
Equity Research Division

Ravina Consulting
Pattamal Plaza
3rd Cross Kamanahalli
BANGALORE 560084

For Free Stock Advise + Ideas
sowmya@ravinaconsulting.com
Talk / SMS 08105737966

Read - www.ingeniousinvestor.blogspot.com
Follow us - www.twitter.com/smartinvestor

Sunday, January 29, 2012

JSW Steel - Sell


JSW Steel came out with its Q3 numbers on Friday and they show a decent performance in terms of volumes that rose by 20 per cent YoY. In the September quarter of 2011 the volumes were up by 19 per cent on a YoY basis. However, the volume scenario compared to the previous quarter remains the same as it grew only by 1 per cent whereas in the previous quarter the QoQ growth was by 10 per cent to 1.88 tonnes.

The net sales of the company stood at Rs 7,859.62 crore, higher by 35 per cent as compared to the previous year’s same quarter due to higher sales volume and flat realisation levels. The steel prices during the quarter remained flat as compared to Q2FY12. However, the operating performance of the company was a little disappointing. Its EBITDA on a QoQ basis declined by 3.36 per cent and grew by 25.2 per cent on a YoY basis to Rs 1,252 crore.
Meanwhile, the EBITDA margin continued to decline by 130 bps to 15.9 per cent due to higher coking coal cost and raw material cost which was by up by 46 per cent and 47 per cent respectively. Coking coal’s Australian FOB prices came down from USD 300 per tonne in September 2011 to USD 235 in December 2011. The gains, though, were negated by the higher rupee depreciation against the dollar. 

About the present scenario the company has stated that the demand in India has remained modest in the last six months due to weak global demand coupled with higher interest rate and high inflation which led to delay in consumption and new capex plans. The world steel production fell significantly from a peak of 130 million tonnes in May 2011 to 115 million tonnes in November 2011. And in India the demand for steel grew by a mere 1.8 per cent from April to October. The company has further stated that the month of December has witnessed a rebound in demand.

Our Recommendation :

The scrip was hovering around Rs.560 levels on 9th January 2012 and has since jumped to Rs. 680 levels giving a decent return to existing shareholders.  Investors should exit at the current price and re-enter on steep declines to Rs.500 levels.

Bought to you by

Ingenious Investor
Equity Research Division

Ravina Consulting
Pattamal Plaza
3rd Cross Kamanahalli
BANGALORE 560084

For Free Stock Advise + Ideas
sowmya@ravinaconsulting.com
Talk / SMS 08105737966

Read - www.ingeniousinvestor.blogspot.com
Follow us - www.twitter.com/smartinvestor


Stides Arcolab - Buy on declines

Strides Arcolab, a Bangalore-headquartered pharma company has sold its subsidiary Ascent Pharmahealth at an enterprise value of AU$ 375 million (about Rs 1,968 crore) to Watson Pharmaceuticals. The company is currently going through a restructuring phase. 

Strides had acquired a majority stake (50.1 per cent) in Australia-based Ascent Pharmahealth in August 2008. According to the news agency Reuters, this acquisition was valued at the price of AU$ 65 million (about Rs 260 crore). The company later had increased its shareholding up to 60.3 per cent. 

Ascent is one of the leading generics company in Australia. This company also has nine subsidiaries in countries like New Zealand, Singapore, Hong Kong, Malaysia and Brunei.  Ascent brought about 33 per cent of the revenues of Strides in CY2010. Ascent has grown by a healthy five-year compounded annual growth rate (CAGR) of 30 per cent in the topline. For the year 2010 the company reported sales of AU$ 132.3 million (about Rs 550 crore) while its net profit remained AU$ 12 million (about Rs 50 crore).

Its EBITDA margins remained at about 13 per cent, lower than the EBITDA margins of Strides (22 per cent) in the same year. For the year 2010 the company showed a growth rate of 26 per cent in topline and 30 per cent in the bottomline. This high growth has mainly arisen due to the high growth rates in the Australian pharma market. 

The Australian government has proposed a cut of 23 per cent in the pharma product prices from April 2012. Though the company is leading player in the Australian generics market, we believe that this would impact the margins of Ascent. 

Looking at the value that Strides has got for selling Ascent, we believe it will have a good impact on its balance-sheet. Its total debt as of June 2011 half-yearly result was Rs 2,419.51 crore. The company paid Rs 90 crore as half-yearly interest expense which works out to be Rs 180 crore of annual interest payment in 2011. Its interest cover ratio as per the same statement works out to be 2.15 which has decreased from 2.97 in the same period last year. Its debt to equity ratio stood at 0.74 in June 2011. In our opinion company will use the amount received from the Ascent deal to pay the debt and bring these ratios down. 

The company recently has also said that it will mainly focus on the injectable and specialties segment in which it has recently received many USFDA approvals. As we see it, the company is in a very good shape to take the benefit of these approvals in the coming years. Strides’ specialties division, Agila, is also doing well. In 2010 its revenues rose by 84 per cent and contributed about 39 per cent to the topline and 32 per cent in the EBITDA. 

Our Recommendation :
With the good price received for Ascent and many new products in the pipeline we believe that this stock will be an attractive bet going ahead. Investors could start looking to accumulate the stock during the dips.


Investors should buy the scrip on all declines to Rs.400 levels and target for a Rs.600 with a holding period of 12-15 months.



Bought to you by


Ingenious Investor
Equity Research Division


Ravina Consulting
Pattamal Plaza
3rd Cross Kamanahalli
BANGALORE 560084


For Free Stock Advise + Ideas
sowmya@ravinaconsulting.com
Talk / SMS 08105737966


Read - www.ingeniousinvestor.blogspot.com
Follow us - www.twitter.com/smartinvestor